20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Choosing a Cabazitaxel Intermediate: Factors for Pharmaceutical Procurement

For procurement professionals in the pharmaceutical sector, sourcing critical intermediates like 7,10-Dimethoxy-10-DAB III (CAS: 183133-94-0) requires a strategic approach. This compound serves as a key building block for Cabazitaxel, an important chemotherapy drug. Successfully integrating this intermediate into your supply chain necessitates a clear understanding of market dynamics and supplier capabilities. When searching to 'buy 7,10-dimethoxy-10-dab iii', buyers often look for reliability and competitive pricing.

A primary consideration when selecting a supplier is their role as a manufacturer. A direct 7,10-dimethoxy-10-dab iii manufacturer can often provide better control over quality, lead times, and pricing. Chinese manufacturers are significant players in this market, making '7,10-dimethoxy-10-dab iii supplier in China' a common search term for global buyers. However, it’s crucial to vet these suppliers thoroughly.

Key factors for procurement managers include not only the 'cabazitaxel intermediate price' but also the supplier's ability to meet purity specifications (typically ≥98.0% for CAS 183133-94-0), their production capacity, and their adherence to Good Manufacturing Practices (GMP) if applicable for later-stage development. The pharmaceutical procurement process involves assessing the supplier's track record, their responsiveness to inquiries, and their logistical capabilities.

Furthermore, understanding the broader market for API intermediates is essential. Factors such as regulatory changes, raw material availability, and global demand for Cabazitaxel can influence the supply and pricing of 7,10-Dimethoxy-10-DAB III. Building a strong partnership with a dependable chemical intermediate supplier who can navigate these complexities is a significant advantage.

In conclusion, the procurement of essential intermediates like 7,10-Dimethoxy-10-DAB III demands a careful evaluation of suppliers. By focusing on quality, reliability, and strategic partnerships, pharmaceutical companies can ensure a stable supply chain for their critical drug development projects.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Why High-Purity 7,10-Dimethoxy-10-DAB III Matters for Drug Synthesis

Next: Understanding the Role of 7,10-Dimethoxy-10-DAB III in Oncology Drug Development

All Rights Reserved